March 17, 2026
A Delaware federal judge on Tuesday closed the book on a vascular port patent dispute between C.R. Bard and AngioDynamics that had been pending for over 11 years, citing a settlement after the Federal Circuit invalidated Bard patents that a jury said AngioDynamics infringed.
June 16, 2023
AngioDynamics is seeking attorney fees after a Delaware judge earlier this month invalidated C.R. Bard patents on implanted catheter receptacles that a jury had found AngioDynamics infringed.
June 01, 2023
A federal judge has determined that three C.R. Bard patents — which a jury found last year had been infringed by AngioDynamics' implantable port products — were actually invalid for multiple reasons.
January 31, 2023
AngioDynamics says it should get a new trial after a Delaware federal jury found the company's implantable port products infringed medical device maker C.R. Bard's patents, claiming that "Bard's trial presentation was littered with improper and prejudicial arguments."
December 12, 2022
C.R. Bard and AngioDynamics have laid out different time frames on when a Delaware federal court should schedule a damages trial after a jury last month found AngioDynamics' implantable port products infringed Bard's patents.
November 23, 2022
A Delaware federal jury has determined that some of AngioDynamics' implantable port products infringed medical device maker C.R. Bard's patents, with the company saying in a U.S. Securities and Exchange Commission report Wednesday that it "strongly disagrees" with the verdict.
April 22, 2022
COVID-19 will delay trial in medical device maker C.R. Bard's patent suit against AngioDynamics after a member of the defense team contracted the virus, a Delaware federal judge said Friday.
March 03, 2022
A federal magistrate judge has refused to pause medical device maker C.R. Bard's lawsuit accusing AngioDynamics of infringing three patents, despite a pending appeal in another case Bard filed against a separate company involving separate patents.
April 26, 2019
A Delaware federal judge on Friday tossed a lawsuit by a subsidiary of medical device maker C.R. Bard Inc. accusing rival AngioDynamics Inc. of infringing three patents related to identifying vascular access ports and seeking $67.5 million, finding that the labeling of the ports is "old technology" that cannot be patented.
March 04, 2019
A subsidiary of medical device maker C.R. Bard Inc. told a Delaware federal jury Monday that it is owed $67.5 million in damages from competitor AngioDynamics Inc. for its infringement of three patents related to fluid injection port technology.